G2P
  • Home
  • About
    • About G2P
    • Team
    • Director
    • Institutional Partners
    • Alumni
    • Join Us
  • Research
    • All Research
    • G2P Projects
      • All G2P Projects
      • The BabySeq Project
      • The PeopleSeq Consortium
      • The PopSeq Project
      • The REVEAL-SCAN Project
      • The MilSeq Project
      • The MedSeq Project
      • The PGen Study
      • The REVEAL Study
    • Collaborative Projects
      • All Collaborative Projects
      • Econogenomics Working Group
      • Genomes2Veterans
      • Genomics and Life Insurance Working Group
      • Imagenetics METRICS
  • Publications
  • Presentations
  • News & Media
  • Giving
    • Ways to Give
    • The Franca Fund
    • FAQs
  • Contact Us
Mass General Brigham Broad Institute Harvard Medical School
We're integrating genomics into medicine and society, and advocating for the future of medicine and health
We're adding to the evidence needed to see genomic information used routinely in healthcare
BabySeq results show that newborn genomic sequencing detected unanticipated disease risk factors
Thrilled to announce the Franca Sozzani Fund for Preventive Genomics 
From Boston to Brazil and Texas to Australia, see where G2P team members are speaking next
Nation’s first academic clinic to offer comprehensive DNA sequencing and genetic risk assessment to healthy adults and children

We conduct research to accelerate the implementation of genomic medicine and the promise of precision health.

Latest News From Genomes2People

February 2021
G2P News
G2P Newsletter February 2021
More...
February 2021
Press
I’m 28 and I don’t know my family history – here’s how that affects my health
More...
February 2021
G2P Blog
A pharmacist’s journey into genomic medicine
More...

Publications

Nature Medicine | June 2020
Biobanks could identify medically actionable findings relevant for COVID-19 clinical care
European Journal of Human Genetics | May 2020
The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

Research

Genome sequencing (GS) is increasingly conducted in large-scale human research studies, creating questions for investigators about whether and how to return genetic findings. The American College of Medical Genetics and Genomics (ACMG) recommends that physicians report secondary findings in at least 59 actionable genes (the ACMG59) whenever clinical GS is ordered. In an effort to … Continued
Learn More >

The BabySeq Project, funded by the NIH, is examining the use of whole exome sequencing to screen newborns for genetic childhood disease risk. BabySeq follows the pediatricians’ incorporation of genetic information into the baby’s medical care. BabySeq aims to collect the data needed to examine what the risks and benefits of newborn genome sequencing might be as we imagine implementing into everyday care.

Learn More >

The MilSeq Project, funded by the Department of Defense through the Air Force Medical Support Agency, is a pilot study examining the process of incorporating whole exome sequencing (WES) into the United States Air Force (USAF) military health system. Active-duty service members of the USAF (Airmen) are enrolled into the study to undergo clinical WES.

Learn More >
How to Help
give now



Every gift matters. Please donate today and help us push the boundaries of medicine by advancing the use of genomics in health care.

Subscribe
subscribe

Stay connected with our
quarterly newsletter

subscribe

From @Genomes2People

RobertCGreenRobert C. Green@RobertCGreen·
19h

Not only are manifested rare diseases not "rare" in aggregate, but in NIH-funded #MedSeq & #BabySeq, over 10% "healthy" individuals have dominant/bi-allelic mutations they are not aware of & that have already or may eventually affect their health. #RareDiseaseDay #tipoftheiceburg

Reply on Twitter 1366081312256368644Retweet on Twitter 13660813122563686449Like on Twitter 136608131225636864428Twitter 1366081312256368644
Genomes2PeopleGenomes2People@Genomes2People·
15h

#RareDiseaseDay #ShowYourStripes

Reply on Twitter 1366140032612982786Retweet on Twitter 1366140032612982786Like on Twitter 13661400326129827863Twitter 1366140032612982786
justinehorneRDJustine Horne PhD RD@justinehorneRD·
26 Feb

I'm thrilled to be working with @RobertCGreen and the @Genomes2People team as a visiting postdoc. I believe it is important to surround yourself with people who inspire and challenge you, and this group certainly does just that! 🧬📈💻⚕️

https://www.genomes2people.org/about/team/

Reply on Twitter 1365361969717538820Retweet on Twitter 13653619697175388202Like on Twitter 136536196971753882011Twitter 1365361969717538820
Genomes2PeopleGenomes2People@Genomes2People·
26 Feb

2 days out from #RareDiseaseDay2021

Did you know that 30 million people in the United States have a rare disease? Rare diseases are more common than you would think. Check out @RareDiseases for more information on many of these conditions!

Reply on Twitter 1365342792873107457Retweet on Twitter 13653427928731074572Like on Twitter 13653427928731074572Twitter 1365342792873107457
justinehorneRDJustine Horne PhD RD@justinehorneRD·
26 Feb

New study shows use of SNP chips to detect very rare pathogenic variants is extremely unreliable. https://www.bmj.com/content/372/bmj.n214?utm_source=twitter&utm_medium=social&utm_term=hootsuite&utm_content=sme&utm_campaign=usage

This is sparking important conversations in the consumer genetics space
@Genomes2People @RobertCGreen @jasonvassy

Reply on Twitter 1365336506861297676Retweet on Twitter 13653365068612976765Like on Twitter 13653365068612976767Twitter 1365336506861297676

Research In Translational Genomics and Health Outcomes
Genomes to People
G2P Program
Brigham and Women’s Hospital
Harvard Medical School
41 Avenue Louis Pasteur, Suite 301
Boston, MA 02115
Tel: (617) 264-5838
genomes2people.org
  • Home
  • About
  • Research
  • Publications
  • Presentations
  • News & Media
  • Giving
  • Contact Us